I analyze the effects of four types of medical innovation and cancer incidence on US cancer mortality rates during the …-adjusted cancer mortality rate during 2000–2009. Drug innovation and imaging innovation are estimated to have reduced the cancer … period 2000–2009, by estimating difference-in-differences models using longitudinal (annual) data on ∼60 cancer sites (breast …

I assess the impact that pharmaceutical innovation had on cancer mortality in Mexico during the period 2003-2013, by ….) that were subject to more pharmaceutical innovation, controlling for changes in the age-standardized cancer incidence rate … of cancer drug innovation to Mexican longevity growth has been valuable, but, perhaps, it could have been even larger …

This study examines the impact of pharmaceutical innovation and other factors on the survival of U.S. cancer patients … innovation accounted for 74% of the increase in the 1-year observed survival rate for all cancer sites combined during the period … during the period 1992-2003. In particular, it investigates whether cancer survival rates increased more for those cancer …